Gilder Biotech Report Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gilder Biotech Report

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Cosmo Daisey who started this subject	9/19/2001 5:25:52 PM
From: Cosmo Daisey	Read Replies (1) of 25

The inaugural issue is very interesting and easy to read. There is a new approach to research emerging with several small biotechs paving the way as well as some giants in biotech involved. Vertex (VRTX) was profiled in this issue as a company on the leading edge of the new technology. VRTX hit a new 52 week low today, reversed and closed up .90 @ 26.55. This is sometimes the sign of a bottom and I noticed several other stocks traded the same way today. I don't think it is the Gilder effect as the biotech report has been on my desk for a couple of weeks. Of the seven stocks mentioned in the letter, five were up today. Cosmo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext